Efficacy and Safety of "Treat-and-Extend" Regimen Versus "Pro Re Nata" of Conbercept in Age-related Macular Degeneration
Clinical trial NCT02802657 · UNKNOWN
Trial details
- NCT number
- NCT02802657
- Sponsor
- Xiaodong Sun
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2020-09-01
- Enrollment
- 141
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.